Dietary antioxidants protect hematopoietic cells and improve animal survival after total-body irradiation

Radiation Research

Volumn 169, Issue 4, 2008, Pages 384-396

  Wambi, Chris ^a   Sanzari, Jenine ^a   Wan, X Steven ^a   Nuth, Manunya ^a   Davis, James ^a   Ko, Ying Hui ^a   Sayers, Carly M ^a   Baran, Matthew ^a   Ware, Jeffrey H ^a   Kennedy, Ann R ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b 195 John Morgan Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL SUCCINATE; ANTIOXIDANT; ASCORBIC ACID; CASPASE 9; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; SELENOMETHIONINE SE 75; THIOCTIC ACID; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL COUNT; BONE MARROW CELL; CELL PROTECTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; HEMATOPOIETIC CELL; LETHAL DOSE; LYMPHOCYTOPENIA; MALE; MOUSE; NEUTROPENIA; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PROTECTION; SURVIVAL; SURVIVAL TIME; WHOLE BODY RADIATION; X RAY;

ANIMALS; ANTIOXIDANTS; BONE MARROW CELLS; DIET; HEMATOPOIETIC STEM CELLS; LEUKOCYTE COUNT; MALE; MICE; MICE, INBRED ICR; NEUTROPHILS; RADIATION-PROTECTIVE AGENTS; TRANSFORMING GROWTH FACTOR BETA1; WHOLE-BODY IRRADIATION;

ANIMALIA; MUS;

EID: 42949175815     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1204.1     Document Type: Article

References (65)

1. K. L. Koenig, R. E. Goans, R. J. Hatchett, F. A. Mettler, Jr., T. A. Schumacher, E. K. Noji and D. G. Jarrett, Medical treatment of radiological casualties: current concepts. Ann. Emerg. Med. 45, 643-652 (2005).
2. C. N. Coleman, W. F. Blakely, J. R. Fike, T. J. MacVittie, N. F. Metting, J. B. Mitchell, J. E. Moulder, R. J. Preston, T. M. Seed and R. S. Wong, Molecular and cellular biology of moderate-dose (1-10 Gy) radiation and potential mechanisms of radiation protection: Report of a workshop at Bethesda, Maryland, December 17-18, 2001. Radiat. Res. 159, 812-834 (2003).
3. F. A. Mettler, Jr. and G. L. Voelz, Major radiation exposure - what to expect and how to respond. N. Engl. J. Med. 346, 1554-1561 (2002).
4. F. Herodin and M. Drouet, Cytokine-based treatment of accidentally irradiated victims and new approaches. Exp. Hematol. 33, 1071-1080 (2005).
5. A. D. Augustine, T. Gondre-Lewis, W. McBride, L. Miller, T. C. Pellmar and S. Rockwell, Animal models for radiation injury, protection and therapy. Radiat. Res. 164, 100-109 (2005).
6. T. C. Pellmar and S. Rockwell, Priority list of research areas for radiological nuclear threat countermeasures. Radiat Res. 163, 115-123 (2005).
7. H. B. Stone, J. E. Moulder, C. N. Coleman, K. K. Ang, M. S. Anscher, M. H. Barcellos-Hoff, W. S. Dynan, J. R. Fike, D. J. Grdina and D. Zaharevitz, Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiat. Res. 162, 711-728 (2004).
8. C. N. Coleman, H. B. Stone, J. E. Moulder and T. C. Pellmar, Modulation of radiation injury. Science 304, 693-694 (2004).
9. M. Drouet, F. Mourcin, N. Grenier, V. Leroux, J. Denis, J. F. Mayol, P. Thullier, J. J. Lataillade and F. Herodin, Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression: long-term follow-up of hematopoiesis. Blood 103, 878-885 (2004).
10. A. M. Farese, D. B. Casey, W. G. Smith, R. M. Vigneulle, J. P. McKearn and T. J. MacVittie, Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration. Stem Cells 19, 522-553 (2001).
11. F. Herodin, P. Bourin, J. F. Mayol, J. J. Lataillade and M. Drouet, Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma-irradiation promotes survival. Blood 101, 2609-2616 (2003).
12. T. J. MacVittie, A. M. Farese, W. G. Smith, C. M. Baum, E. Burton and J. P. McKearn, Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression. Blood 95, 837-845 (2000).
13. A. M. Farese, F. Herodin, J. P. McKearn, C. Baum, E. Burton and T. J. MacVittie, Acceleration of hematopoietic reconstitution with a synthetic cytokine (SC-55494) after radiation-induced bone marrow aplasia. Blood 87, 581-591 (1996).
14. J. F. Weiss and M. R. Landauer, Radioprotection by antioxidants. Ann. NY Acad. Sci. 899, 44-60 (2000).
15. J. F. Weiss and M. R. Landauer, Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 189, 1-20 (2003).
16. M. Konopacka, O. Palyvoda and J. Rzeszowska-Wolny, Inhibitory effect of ascorbic acid post-treatment on radiation-induced chromosomal damage in human lymphocytes in vitro. Teratog. Carcinog. Mutagen. 22, 443-450 (2002).
17. M. Konopacka and J. Rzeszowska-Wolny, Antioxidant vitamins C, E and beta-carotene reduce DNA damage before as well as after gamma-ray irradiation of human lymphocytes in vitro. Mutat. Res. 491, 1-7 (2001).
18. K. Umegaki, S. Aoki and T. Esashi, Whole body X-ray irradiation to mice decreases ascorbic acid concentration in bone marrow: comparison between ascorbic acid and vitamin E succinate. Free Radic. Biol. Med. 19, 493-497 (1995).
19. K. Umegaki, M. Sano, K. Suzuki, I. Tomita and T. Esashi, Increases in 4-hydroxynonenal and hexanal in bone marrow of rats subjected to total body X-ray irradiation: association with antioxidant vitamins. Bone Marrow Transplant. 23, 173-178 (1999).
20. L. M. Calvi, G. B. Adams, K. W. Weibrecht, J. M. Weber, D. P. Olson, M. C. Knight, R. P. Martin, E. Schipani, P. Divieti and D. T. Scadden, Osteoblastic cells regulate the hematopoietic stem cell niche. Nature 425, 841-846 (2003).
21. A. R. Kennedy, J. H. Ware, J. Guan, J. J. Donahue, J. E. Biaglow, Z. Zhou, J. Stewart, M. Vazquez and X. S. Wan, Selenomethionine protects against adverse biological effects induced by space radiation. Free Radic. Biol. Med. 36, 259-266 (2004).
22. X. S. Wan, P. Bloch, J. H. Ware, Z. Zhou, J. J. Donahue, J. Guan, J. Stewart and A. R. Kennedy, Detection of oxidative stress induced by low-and high-linear energy transfer radiation in cultured human epithelial cells. Radiat. Res. 163, 364-368 (2005).
23. J. Guan, J. Stewart, J. H. Ware, Z. Zhou, J. J. Donahue and A. R. Kennedy, Effects of dietary supplements on the space radiation-induced reduction in total antioxidant status in CBA mice. Radiat. Res. 165, 373-378 (2006).
24. J. Guan, X. S. Wan, Z. Zhou, J. Ware, J. J. Donahue, J. E. Biaglow and A. R. Kennedy, Effects of dietary supplements on space radiation-induced oxidative stress in Sprague-Dawley rats. Radiat. Res. 162, 572-579 (2004).
25. A. Prentice, F. Branca, T. Decsi, K. F. Michaelsen, R. J. Fletcher, P. Guesry, F. Manz, M. Vidailhet, D. Pannemans and S. Samartin, Energy and nutrient dietary reference values for children in Europe: methodological approaches and current nutritional recommendations. Br. J. Nutr. 92 (Suppl. 2), S83-S146 (2004).
26. M. L. Aitio, N-acetylcysteine - passe-partout or much ado about nothing? Br. J. Clin. Pharmacol. 61, 5-15 (2006).
27. S. D. Wollin and P. J. Jones, Alpha-lipoic acid and cardiovascular disease. J. Nutr. 133, 3327-3330 (2003).
28. X. S. Wan, J. H. Ware, Z. Zhou, J. J. Donahue, J. Guan and A. R. Kennedy, Protection against radiation-induced oxidative stress in cultured human epithelial cells by treatment with antioxidant agents. Int. J. Radiat. Oncol. Biol. Phys. 64, 1475-1481 (2006).
29. J. M. Bertho, J. Frick, M. Prat, C. Demarquay, N. Dudoignon, F. Trompier, N. C. Gorin, D. Thierry and P. Gourmelon, Comparison of autologous cell therapy and granulocyte-colony stimulating factor (G-CSF) injection vs. G-CSF injection alone for the treatment of acute radiation syndrome in a non-human primate model. Int. J. Radiat. Oncol. Biol. Phys. 63, 911-920 (2005).
30. A. M. Farese, D. B. Casey, R. M. Vigneulle, N. R. Siegel, R. F. Finn, J. A. Klover, W. G. Smith, J. P. McKearn and T. J. MacVittie, A single dose of pegylated leridistim significantly improves neutrophil recovery in sublethally irradiated rhesus macaques. Stem Cells 19, 514-521 (2001).
31. T. J. MacVittie, A. M. Farese, F. Herodin, L. B. Grab, C. M. Baum and J. P. McKearn, Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor. Blood 87, 4129-4135 (1996).
32. J. Liebmann, A. M. DeLuca, A. Epstein, S. M. Steinberg, G. Morstyn and J. B. Mitchell, Protection from lethal irradiation by the combination of stem cell factor and tempol. Radiat. Res. 137, 400-404 (1994).
33. N. Dainiak, Hematologic consequences of exposure to ionizing radiation. Exp. Hematol. 30, 513-528 (2002).
34. T. Iyoda, K. Nagata, M. Akashi and Y. Kobayashi, Neutrophils accelerate macrophage-mediated digestion of apoptotic cells in vivo as well as in vitro. J. Immunol. 175, 3475-3483 (2005).
35. E. Uchimura, N. Watanabe, O. Niwa, M. Muto and Y. Kobayashi, Transient infiltration of neutrophils into the thymus in association with apoptosis induced by whole-body X-irradiation. J. Leukoc. Biol. 67, 780-784 (2000).
36. J. Albanese and N. Dainiak, Regulation of TNFRSF6 (Fas) expression in ataxia telangiectasia. Radiat. Res. 154, 616-624 (2000).
37. V. M. Peterson, J. J. Adamovicz, T. B. Elliott, M. M. Moore, G. S. Madonna, W. E. Jackson, 3rd, G. D. Ledney and W. C. Gause, Gene expression of hematoregulatory cytokines is elevated endogenously after sublethal gamma-irradiation and is differentially enhanced by therapeutic administration of biologic response modifiers. J. Immunol. 153, 2321-2330 (1994).
38. M. Prat, C. Demarquay, J. Frick, D. Thierry, N. C. Gorin and J. M. Bertho, Radiation-induced increase in plasma Flt3 ligand concentration in mice: evidence for the implication of several cell types. Radiat. Res. 163, 408-417 (2005).
39. G. B. Adams, R. P. Martin, I. R. Alley, K. T. Chabner, K. S. Cohen, L. M. Calvi, H. M. Kronenberg and D. T. Scadden, Therapeutic targeting of a stem cell niche. Nat. Biotechnol. 25, 238-243 (2007).
40. J. M. Bertho, C. Demarquay, J. Frick, C. Joubert, S. Arenales, N. Jacquet, I. Sorokine-Durm, Q. Chau, M. Lopez and P. Gourmelon, Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia. Int. J. Radiat. Biol. 77, 703-712 (2001).
41. A. Huchet, Y. Belkacemi, J. Frick, M. Prat, I. Muresan-Kloos, D. Altan, A. Chapel, N. C. Gorin, P. Gourmelon and J. M. Bertho, Plasma Flt-3 ligand concentration correlated with radiation-induced bone marrow damage during local fractionated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 57, 508-515 (2003).
42. M. Iiyama, K. Kakihana, T. Kurosu and O. Miura, Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signalling and in cell cycle progression. Cell Signal. 18, 174-182 (2006).
43. M. Sattler, T. Winkler, S. Verma, C. H. Byrne, G. Shrikhande, R. Salgia and J. D. Griffin, Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 93, 2928-2935 (1999).
44. L. Sarma and P. C. Kesavan, Protective effect of vitamins C and E against gamma-ray-induced chromosomal damage in mouse. Int. J. Radiat. Biol. 63, 759-764 (1993).
45. E. K. Ortmann, T. Mayerhofer, N. Getoff and R. Kodym, Effect of antioxidant vitamins on radiation-induced apoptosis in cells of a human lymphoblastic cell line. Radiat. Res. 161, 48-55 (2004).
46. J. M. Adams and S. Cory, The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26, 1324-1337 (2007).
47. N. O. Fortunel, J. A. Hatzfeld, M. N. Monier and A. Hatzfeld, Control of hematopoietic stem/progenitor cell fate by transforming growth factor-beta. Oncol. Res. 13, 445-453 (2003).
48. S. E. Jacobsen, O. P. Veiby, J. Myklebust, C. Okkenhaug and S. D. Lyman, Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-beta and tumor necrosis factor-alpha. Blood 87, 5016-5026 (1996).
49. J. M. Scandura, P. Boccuni, J. Massague and S. D. Nimer, Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc. Natl. Acad. Sci. USA 101, 15231-15236 (2004).
50. J. Domen, K. L. Gandy and I. L. Weissman, Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood 91, 2272-2282 (1998).
51. S. Alvarez, P. Drane, A. Meiller, M. Bras, V. Deguin-Chambon, V. Bouvard and E. May, A comprehensive study of p53 transcriptional activity in thymus and spleen of gamma irradiated mouse: high sensitivity of genes involved in the two main apoptotic pathways. Int. J. Radiat. Biol. 82, 761-770 (2006).
52. -/- mice. J. Radiat. Res. (Tokyo) 41, 113-127 (2000).
53. A. A. Kapasi and P. C. Singhal, Aging splenocyte and thymocyte apoptosis is associated with enhanced expression of p53, bax, and caspase-3. Mol. Cell. Biol. Res. Commun. 1, 78-81 (1999).
54. A. M. Samuni, U. Kasid, E. Y. Chuang, S. Suy, W. Degraff, M. C. Krishna, A. Russo and J. B. Mitchell, Effects of hypoxia on radiation-responsive stress-activated protein kinase, p53, and caspase 3 signals in TK6 human lymphoblastoid cells. Cancer Res. 65, 579-586 (2005).
55. W. S. Wu, S. Heinrichs, D. Xu, S. P. Garrison, G. P. Zambetti, J. M. Adams and A. T. Look, Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 123, 641-653 (2005).
56. S. E. Jacobsen, C. Okkenhaug, J. Myklebust, O. P. Veiby and S. D. Lyman, The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J. Exp. Med. 181, 1357-1363 (1995).
57. N. O. Fortunel, A. Hatzfeld and J. A. Hatzfeld, Transforming growth factor-beta: pleitropic role in the regulation of hematopoiesis. Blood 96, 2022-2036 (2000).
58. C. M. Chang, A. Limanni, W. H. Baker, M. E. Dobson, J. F. Kalinich, W. Jackson and M. L. Patchen, Bone marrow and splenic granulocyte-macrophage colony-stimulating factor and transforming growth factor-beta mRNA levels in irradiated mice. Blood 86, 2130-2136 (1995).
59. A. Kurishita, H. Katoh, Y. Uehara, A. Uchida, Y. Mizutani, T. Ono, S. Hirose and S. Okada, Post-irradiation treatment with OK432 can prevent radiation-induced bone marrow death. Int. J. Radiat. Biol. 59, 711-716 (1991).
60. G. D. Ledney, T. B. Elliott, M. R. Landauer, R. M. Vigneulle, P. L. Henderson, R. A. Harding and S. P. Tom, Jr., Survival of irradiated mice treated with WR-151327, synthetic trehalose dicorynomycolate, or ofloxacin. Adv. Space Res. 14, 583-586 (1994).
61. I. Brook, T. J. MacVittie and R. I. Walker, Recovery of aerobic and anaerobic bacteria from irradiated mice. Infect. Immun. 46, 270-271 (1984).
62. M. Nose, A. Uzawa, T. Ogyu and G. Suzuki, OK-432 reduces mortality and bacterial translocation in irradiated and granulocyte-colony stimulating factor (G-CSF)-treated mice. J. Radiat. Res. (Tokyo) 42, 191-200 (2001).
63. T. J. MacVittie, A. M. Farese and W. Jackson, 3rd, Defining the full therapeutic potential of recombinant growth factors in the post radiation-accident environment: the effect of supportive care plus administration of G-CSF. Health Phys. 89, 546-555 (2005).
64. J. F. Weiss, Pharmacologic approaches to protection against radiation-induced lethality and other damage. Environ. Health Perspect. 105 (Suppl. 6), 1473-1478 (1997).
65. D. Hershman, A. I. Neugut, J. S. Jacobson, J. Wang, W. Y. Tsai, R. McBride, C. L. Bennett and V. R. Grann, Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J. Natl. Cancer Inst. 99, 196-205 (2007).